Affinage

PPDPF

Pancreatic progenitor cell differentiation and proliferation factor · UniProt Q9H3Y8

Length
114 aa
Mass
11.8 kDa
Annotated
2026-06-10
14 papers in source corpus 11 papers cited in narrative 15 extracted findings
Cross-family judge faithfulness: 5/6 claims corpus-supported (83%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PPDPF (EXDPF/C20orf149) is a small multifunctional adaptor and enzyme that couples developmental, metabolic, and oncogenic signaling, and was first defined as a Ptf1a-regulated, retinoic-acid-dependent driver of exocrine pancreas cell proliferation in zebrafish, where its loss triggers cell-cycle arrest through induction of p21, p27, and cyclin G1 (PMID:19067490). Its best-characterized biochemical activities are direct: PPDPF binds GTP and transfers it to SOS1 to enhance SOS1 GEF activity and KRAS activation, with GTP-binding and SOS1-interaction mutants abolishing this function (PMID:36453576), and it acts as a thiol-disulfide oxidoreductase that supports NMNAT activity to maintain NAD+ and mitochondrial homeostasis (PMID:40106551). A recurring mechanistic theme is that PPDPF modulates signaling by disrupting or scaffolding specific protein-protein interactions: it interferes with the CK1α–Axin interaction to dismantle the β-catenin destruction complex and activate Wnt/β-catenin (PMID:37477088), blocks STAT3–PTPN1 binding to hyperactivate STAT3 (PMID:35906391), disrupts c-Myc–GSK3β association to stabilize c-Myc and drive CD24-mediated immune escape (PMID:40774693), and prevents assembly of the metabolic carboxylase pairs MCCA–MCCB and PCCA–PCCB to block leucine and methionine catabolism and feed mTORC1 and SAM pools (PMID:40025229, PMID:39694223). PPDPF also scaffolds ubiquitination events, recruiting TRIM21 to catalyze K63-linked ubiquitination of RIPK1 at K140 to activate NF-κB (PMID:37027301) and blocking MDM2-mediated ubiquitination of BABAM2 to confer radioresistance (PMID:34975328). Its own abundance is controlled post-translationally, being stabilized by IL6/JAK2-mediated phosphorylation at Tyr16/Tyr17 (PMID:37477088) and by the opposing actions of the E3 ligase ARIH2 and deubiquitinase OTUD4 under amino acid starvation (PMID:40025229). Notably, the developmental role is not conserved: PPDPF knockout in human embryonic stem cells has only a modest effect on pancreatic progenitor development and does not alter lineage specification in vivo (PMID:40193385).

Mechanistic history

Synthesis pass · year-by-year structured walk · 7 steps
  1. 2008 High

    Established the first biological role and upstream regulation of PPDPF, placing its zebrafish ortholog as a retinoic-acid/Ptf1a-controlled effector of exocrine pancreas proliferation.

    Evidence Promoter binding-site analysis, luciferase reporter, morpholino knockdown, mRNA rescue, and cell-cycle gene profiling in zebrafish

    PMID:19067490

    Open questions at the time
    • Molecular activity of the protein itself was not defined
    • Whether the proliferation role generalizes beyond exocrine pancreas was untested
  2. 2022 High

    Defined PPDPF as a direct GTP-binding factor that potentiates SOS1 GEF activity, providing a concrete biochemical mechanism for its RAS-pathway and tumor-promoting effects.

    Evidence GTP-binding and GEF activity assays, active-site mutagenesis, co-IP, and KRASG12D mouse models in pancreatic ductal adenocarcinoma

    PMID:36453576

    Open questions at the time
    • Structural basis of GTP transfer to SOS1 not resolved
    • Whether this activity operates outside pancreatic cancer is unclear
  3. 2022 Medium

    Showed PPDPF acts as an interaction modulator and ubiquitination regulator in lung cancer, interfering with STAT3-PTPN1 and protecting BABAM2 from MDM2.

    Evidence Co-IP, ubiquitination assays, knockout/overexpression, and lung cancer mouse models

    PMID:34975328 PMID:35906391

    Open questions at the time
    • Direct vs indirect nature of the disruption not fully resolved
    • Single-lab mechanistic placement
  4. 2023 High

    Generalized the protein-interaction-disruption and scaffolding model across cancers, linking PPDPF to Wnt/β-catenin activation and to TRIM21-dependent K63-ubiquitination of RIPK1 for NF-κB signaling, and identified JAK2 phosphorylation as a stabilizing input.

    Evidence Co-IP, site-specific ubiquitination assays (RIPK1 K140), phosphorylation-site mapping, organoid and tissue-specific KO mouse models

    PMID:37027301 PMID:37477088

    Open questions at the time
    • How one small protein selects among many distinct partners is unexplained
    • Stoichiometry and structural mode of complex disruption unknown
  5. 2024 Medium

    Extended the interaction-disruption mechanism into amino acid metabolism, with PPDPF blocking PCCA-PCCB assembly to elevate methionine and SAM.

    Evidence Mass spectrometry, co-IP, and metabolite measurements in esophageal squamous cell carcinoma

    PMID:39694223

    Open questions at the time
    • Direct binding interface with PCCA not mapped
    • Single-lab finding
  6. 2025 High

    Defined an intrinsic enzymatic activity (thiol-disulfide oxidoreductase) supporting NMNAT and NAD+ homeostasis, and added further metabolic and immune-evasion mechanisms plus a writer/eraser pair controlling PPDPF stability.

    Evidence Enzymatic and NMNAT activity assays, SILAC and metabolic flux analysis, GST-pulldown, ubiquitination assays, and multiple KO mouse models

    PMID:40025229 PMID:40106551 PMID:40774693

    Open questions at the time
    • How thiol-disulfide oxidoreductase activity reconciles with the GTP-binding and adaptor activities is unknown
    • Whether a single domain mediates all these functions is unresolved
  7. 2025 Medium

    Revealed that the developmental role is not conserved in humans, with PPDPF dispensable for human pancreatic lineage specification, sharpening interpretation of the original zebrafish phenotype.

    Evidence CRISPR/Cas9 knockout in hESCs with pancreatic differentiation and orthotopic transplantation

    PMID:40193385

    Open questions at the time
    • Functional compensation in human cells not ruled out
    • Does not address PPDPF roles in adult/disease tissues

Open questions

Synthesis pass · forward-looking unresolved questions
  • How a single small protein integrates a thiol-disulfide oxidoreductase activity, GTP binding, and a broad set of protein-interaction-disruption events into a coherent structural and regulatory logic remains unresolved.
  • No structure of PPDPF or its complexes reported in the corpus
  • Determinants of partner selectivity unknown
  • Relationship between enzymatic and adaptor functions unexplained

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 6 GO:0060090 molecular adaptor activity 2 GO:0016491 oxidoreductase activity 1
Pathway
R-HSA-162582 Signal Transduction 4 R-HSA-392499 Metabolism of proteins 4 R-HSA-1430728 Metabolism 3

Evidence

Reading pass · 15 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2008 Exdpf (zebrafish ortholog of PPDPF) is a direct transcriptional target of Ptf1a: three consensus Ptf1a binding sites were identified in the exdpf promoter, luciferase assay demonstrated Ptf1a promotes exdpf transcription, and exdpf expression was lost in ptf1a morphants. Promoter analysis, luciferase reporter assay, antisense morpholino knockdown in zebrafish PLoS biology High 19067490
2008 Exdpf (zebrafish ortholog of PPDPF) is required for exocrine pancreas cell proliferation; knockdown causes lineage-specific cell cycle arrest (not apoptosis) mediated by upregulation of p21(Cip), p27(Kip), and cyclin G1. Antisense morpholino knockdown in zebrafish, real-time PCR for cell cycle inhibitor genes PLoS biology High 19067490
2008 Exdpf is genetically downstream of retinoic acid (RA) signaling in exocrine pancreas development: exdpf knockdown abolished RA-induced ectopic cpa expression, and exdpf mRNA injection rescued endogenous cpa expression in embryos treated with a RA signaling inhibitor. Genetic epistasis via morpholino knockdown and mRNA rescue in zebrafish with RA pathway manipulation PLoS biology High 19067490
2022 PPDPF promotes STAT3 hyperactivation by interfering with the STAT3-PTPN1 interaction, leading to increased BMPR2 transcription and inhibition of apoptosis in lung adenocarcinoma. Co-immunoprecipitation, in vitro and in vivo loss-of-function assays, transcriptional analysis Oncogene Medium 35906391
2022 PPDPF interacts with BABAM2 and blocks MDM2-mediated ubiquitination of BABAM2, thereby stabilizing BABAM2 and promoting radioresistance in non-small cell lung cancer cells. Co-immunoprecipitation, ubiquitination assay, KO and overexpression in lung cancer cells and KL mouse model International journal of biological sciences Medium 34975328
2022 PPDPF can bind GTP and transfer GTP to SOS1, thereby enhancing SOS1 GEF activity and promoting KRAS activation in pancreatic ductal adenocarcinoma; mutations at GTP-binding sites of PPDPF or critical SOS1-PPDPF interaction residues severely impair GEF activity and tumor-promoting effects. GTP-binding assay, GEF activity assay, site-directed mutagenesis, co-immunoprecipitation, in vitro and in vivo overexpression/KO, KRASG12D genetic mouse model Advanced science High 36453576
2023 PPDPF interacts with RIPK1 and recruits the E3 ligase TRIM21, which catalyzes K63-linked ubiquitination of RIPK1 at K140, thereby activating NF-κB signaling and suppressing hepatocellular carcinoma development. Co-immunoprecipitation, ubiquitination assay with site-specific (K140) mutant, liver-specific KO and overexpression mouse models (DEN-induced HCC) Cell reports High 37027301
2023 PPDPF interacts with CK1α, disrupting its binding to Axin and disassociating the β-catenin destruction complex, thereby decreasing β-catenin phosphorylation and activating the Wnt/β-catenin pathway in colorectal cancer. Co-immunoprecipitation, phosphorylation assays, intestinal epithelium-specific KO with organoid and AOM/DSS mouse models EMBO reports High 37477088
2023 PPDPF is phosphorylated at Tyr16 and Tyr17 by IL6/JAK2 inflammatory signaling, which stabilizes the PPDPF protein. Phosphorylation site mapping, mutational analysis, IL6/JAK2 pathway manipulation EMBO reports Medium 37477088
2025 PPDPF functions as a thiol-disulfide oxidoreductase that maintains cellular NAD+ levels by supporting nicotinamide mononucleotide adenylyl transferase (NMNAT) activity; PPDPF deficiency impairs NAD+ and mitochondrial homeostasis in proximal tubule cells. Enzymatic activity assay (thiol-disulfide oxidoreductase), NAD+ level measurement, NMNAT activity assay, PPDPF KO mouse models (aging, chemical exposure, obstruction) Science advances High 40106551
2025 PPDPF prevents the interaction between MCCA and MCCB subunits of the methylcrotonyl-CoA carboxylase complex, thereby inhibiting leucine catabolism and activating mTORC1 signaling in cholangiocarcinoma. SILAC metabolic labeling screen, metabolic flux analysis, co-immunoprecipitation, PPDPF KO mouse model Oncogene High 40025229
2025 PPDPF protein stability is regulated by ubiquitination: ARIH2 (E3 ligase) and OTUD4 (deubiquitinase) cooperatively control PPDPF ubiquitination and stability under amino acid starvation conditions. Ubiquitination assay, co-immunoprecipitation with ARIH2 and OTUD4 Oncogene Medium 40025229
2025 PPDPF interferes with c-Myc–GSK3β interaction, enhancing c-Myc protein stability and thereby upregulating CD24 expression to promote immune escape from macrophage phagocytosis in esophageal squamous cell carcinoma. GST-pulldown, co-immunoprecipitation, immunoblotting, fluorescence microscopy-based phagocytosis assay, flow cytometry, KO mouse models Journal for immunotherapy of cancer High 40774693
2024 PPDPF interacts with PCCA (a subunit of propionyl-CoA carboxylase) and inhibits PCCA-PCCB binding, thereby blocking methionine catabolism via the C-Vomit pathway and increasing methionine and SAM levels in esophageal squamous cell carcinoma. Mass spectrometry, co-immunoprecipitation, metabolite measurement in vitro and in vivo Cancer letters Medium 39694223
2025 PPDPF knockout in human embryonic stem cells differentiated toward the pancreatic lineage shows only a very modest effect on pancreatic progenitor development in vitro and does not affect lineage specification upon orthotopic transplantation in vivo, indicating PPDPF is NOT a key regulator of human pancreas development (in contrast to its zebrafish ortholog). CRISPR/Cas9 knockout in hESCs, pancreatic differentiation protocol, orthotopic transplantation in vivo PLoS genetics Medium 40193385

Source papers

Stage 0 corpus · 14 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2019 Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer. Biochemical and biophysical research communications 72 30954221
2008 Exdpf is a key regulator of exocrine pancreas development controlled by retinoic acid and ptf1a in zebrafish. PLoS biology 40 19067490
2023 PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1. Cell reports 20 37027301
2022 PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3. Oncogene 18 35906391
2022 PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 14 36453576
2022 PPDPF Promotes the Progression and acts as an Antiapoptotic Protein in Non-Small Cell Lung Cancer. International journal of biological sciences 13 34975328
2021 The Exocrine Differentiation and Proliferation Factor (EXDPF) Gene Promotes Ovarian Cancer Tumorigenesis by Up-Regulating DNA Replication Pathway. Frontiers in oncology 12 34041032
2023 Phosphorylation of PPDPF via IL6-JAK2 activates the Wnt/β-catenin pathway in colorectal cancer. EMBO reports 11 37477088
2025 PPDPF preserves integrity of proximal tubule by modulating NMNAT activity in chronic kidney diseases. Science advances 4 40106551
2025 PPDPF-mediated regulation of BCAA metabolism enhances mTORC1 activity and drives cholangiocarcinoma progression. Oncogene 3 40025229
2025 PPDPF promotes the progression of esophageal squamous cell carcinoma via c-Myc/CD24 axis. Journal for immunotherapy of cancer 1 40774693
2026 Chemoresistance and Immune Suppression in Gastric Cancer Are Driven by PPDPF Overexpression. Chemical biology & drug design 0 41984037
2025 PPDPF is not a key regulator of human pancreas development. PLoS genetics 0 40193385
2024 PPDPF promotes esophageal squamous cell carcinoma progression by blocking PCCA binding to PCCB and inhibiting methionine catabolism. Cancer letters 0 39694223

Missed literature

Know a paper Affinage missed for PPDPF? Flag it for the maintainers and the community.

No submissions yet.